Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III pediatric study of L-PZQ ODTs for schistosomiasis
PACTR201810634034543Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3 trial of praziquantel, sponsored by Merck KGaA. Started May 2019; status: completed.
02
Drugs
praziquantel
Beyond the preview
Go deeper on PACTR201810634034543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201810634034543.